# ONFI
> **NDA203993** · New Drug Application · Sponsor: LUNDBECK PHARMS LLC · Approved 2012-12-14
## Drug
- **FDA Application Number:** NDA203993
- **Application type:** New Drug Application
- **Brand name:** ONFI
- **Generic name:** CLOBAZAM
- **Active ingredients:** CLOBAZAM
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LUNDBECK PHARMS LLC
- **Manufacturer:** Lundbeck Pharmaceuticals LLC
- **First approval:** 2012-12-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203993)
---
*MORVS · CC0 1.0*